Daehan New Pharm Ceftriaxone Injection 1 Gram (Ceftriaxone Sodium Hydrate)

Adult administration

Adults and children over 12 years: Administer 1~2g (activity) of ceftriaxone once daily by intravenous or intramuscular injection. In cases of severe disease or infections caused by moderately sensitive pathogens, the dose may be increased to 4g (activity) once daily.

Child administration

Newborns (within 14 days of birth): Administer 20~50mg (activity) per kg of body weight once daily, not exceeding 50mg (activity). Infants and children (from 15 days to 12 years): Administer 20~

This medication should not be used with solutions containing calcium. In particular, for newborns or premature infants, it should never be administered because mixing this medication with calcium can cause precipitate, posing risks. Patients with hypersensitivity to this medication or with allergies to cephalosporin or penicillin antibiotics should not use it. Additionally, this medication containing lidocaine should not be administered intravenously. Patients with severe renal impairment may require adjusted dosing or intervals due to prolonged concentration of this medication. During administration of this medication, liver function, kidney function, and blood condition should be monitored regularly to detect adverse reactions early. This medication may produce various side effects such as diarrhea, rash, urticaria, increased liver enzymes, so if symptoms occur, immediate consultation with medical professionals is essential. In particular, if severe allergic reactions or shock symptoms occur, administration should be immediately stopped and emergency care sought. Women who are pregnant or breastfeeding should use this medication with great caution, and it should not be used in newborns or premature infants due to the risk of bilirubin encephalopathy. Elderly individuals may have a higher risk of side effects due to decreased physical functions, so caution is necessary. This medication may interact with other drugs, thus caution is needed when used in conjunction with diuretics, aminoglycoside antibiotics, vitamin K antagonists, etc. When administering, care should be taken in preparing the injection solution and administration method to prevent phlebitis or pain at the injection site, and it is advisable to administer it quickly after dissolving. Prepared solutions should be used as soon as possible, and storage conditions regarding temperature and time should be adhered to.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, peeling skin, pain in mouth/eye mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities with cough + fever, jaundice (skin or eyes turning yellow), extreme lethargy, sudden and very severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination

Mild side effects

• Eosinophilia
• leukopenia
• thrombocytopenia
• diarrhea
• rash
• increased liver enzymes
• headache
• dizziness
• bronchospasm
• itching

This medication should be stored in a sealed container to protect it from exposure to air, and it is advisable to store it at room temperature away from direct sunlight. This way, the effectiveness of the medication can be maintained for a long time.

Appearance

[For domestic use][For export 2][For export 3]: Transparent vial containing a white to pale yellow powder injection [For export 1]: Transparent vial containing a white to pale yellow powder injection (diluent - clear and transparent liquid)

Package unit

5, 10, 20, 50, 100 vials